Endovascular Brain-Computer Interface for Upper-Limb Paralysis
Key facts
- Who runs it
- Wei Wu
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 2 people, planned
- Started
- 2 Nov 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Endovascular Venous BCI Type-A Sensor
- BCI-Triggered Functional Electrical Stimulation
- BCI-Controlled Bionic Robotic Arm
- Record updated
- 13 November 2026
Who can take part
- Age
- 20 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Clinical diagnosis of one of the following movement disorders:; post-stroke hemiplegia, paraplegia due to spinal cord injury, or ALS (limb-onset spinal type or progressive muscular atrophy type)
- Rehabilitation group only: disease duration within 6 months, residual upper-limb motor potential (muscle strength grade >=1), with activatable target motor cortex confirmed by fMRI or magnetoencephalography (MEG)
- Assistance group only: ALS diagnosed by revised El Escorial criteria or severe paraplegia (ASIA grade A/B), with no realistic prospect of recovering voluntary movement
- Age 20 to 75 years
- Life expectancy greater than 12 months
- Normal venous sinus anatomy with two patent jugular veins large enough to accommodate the device and patent bilateral transverse sinuses, confirmed by MRV or CTV within the last 3 months, or willingness to undergo MRV/CTV assessment if venous anatomy is unknown
- Evidence of activation in the target motor cortex near the superior sagittal sinus during limb movement, confirmed by fMRI or MEG
- No significant visual impairment
- Written informed consent signed by the participant or legal guardian
- Clear expressed preference for either short-term sensor removal (approximately 1 month after implantation) or long-term retention until the end of follow-up, documented in a signed preference confirmation form
- Vascular lesions (stenosis, occlusion, aneurysm) requiring further intervention discovered during angiography do not affect eligibility; such treatment may proceed 24 hours after angiography
Who cannot take part
- In the investigator's opinion, unrealistic expectations regarding the benefits, risks, and limitations of implantation or surgery
- Dementia or cognitive impairment sufficient to affect capacity to provide informed consent or to comply with the protocol (e.g., MMSE <24, ECAS, or other assessment), or epileptiform discharges on EEG
- Presence of an active implanted stimulation device (e.g., cardiac pacemaker, deep brain stimulator, spinal cord stimulator)
- Known allergy to contrast agent
- Any bleeding disorder (to be tested for if clinical status is unknown), resistance to aspirin and/or clopidogrel, or any contraindication to antithrombotic therapy
- Allergy to any material contained in the implanted device
- History of deep vein thrombosis or current hormone replacement therapy
- Any serious illness that, in the investigators' opinion, could severely limit the ability to participate in the study
- History of any of the following: cerebral venous sinus thrombosis, venous hypertension, hydrocephalus after cranioplasty, other severe cardiopulmonary disease, or cancer
- Contraindication to angiography, including chronic kidney injury (eGFR <60 mL/min)
- Unwillingness to comply with all study procedures
- Contraindication to MRI, or microbleeds on SWI-MRI
- Pregnancy, pregnancy planned within 1 year, or breastfeeding
- Judged unsuitable for general anesthesia by an anesthesiologist or respiratory physician
- Venous anatomy unsuitable for superior sagittal sinus implantation as assessed by an experienced neurointerventionalist (e.g., isolated dominant superior anastomotic/Trolard vein or other unfavorable venous variants)
- Inability to comply with follow-up, or absence of a family member or caregiver able to attend the consent process and support study visits
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study tests the safety and feasibility of a new type of brain-computer interface (BCI) in people with severe paralysis caused by stroke, spinal cord injury, or amyotrophic lateral sclerosis (ALS). A BCI records signals directly from the brain and uses them to control external devices. In this study, a small stent-shaped sensor (a metal mesh tube carrying tiny electrodes) is placed inside a vein on the surface of the brain through a needle puncture in a large vein below the collarbone, so no open-brain surgery is needed. Once in place, the sensor records brain activity while participants imagine or attempt movements.
Read full original descriptionShow less
Two participants will be enrolled. One participant with stroke-related arm paralysis who still has rehabilitation potential will receive closed-loop functional electrical stimulation (FES): when the BCI detects the intention to move the paralyzed hand, electrical pulses are delivered to the arm muscles, producing real movement and sensory feedback. This pairing of intention and movement may help the brain rebuild damaged pathways. The other participant with ALS or severe paraplegia and no realistic chance of recovering voluntary movement will use the same sensor to control a robotic arm that helps perform daily tasks such as eating, grasping objects, and opening a door.
For both participants, the study lasts about 60 days after sensor implantation. Training sessions last 45 minutes per day during weeks 2 to 4. Imaging (brain CT and CT venography), electroencephalography (EEG), blood tests, and movement or daily-living assessments are performed at regular intervals. After the week-4 evaluation, the sensor is either removed (short-term group) or left in place for continued monitoring (long-term group), based on the participant's own choice made before enrollment and on clinical judgment. The main measures are safety (side effects, blood clots, bleeding, device problems), quality of the recorded brain signals, accuracy of decoding movement intention, and improvement in arm function or daily-task performance.
The 2 groups in the trial
- Rehabilitation Group (BCI-FES)Treatment being tested
Participants with post-stroke hemiplegia who still have rehabilitation potential. After endovascular implantation of the venous BCI Type-A sensor, they receive decoder calibration during week 1, followed by daily 45-minute closed-loop functional electrical stimulation (FES) training during weeks 2 to 4, in which imagined or attempted hand movements decoded from brain signals trigger electrical stimulation of the paralyzed forearm muscles with real-time visual feedback. Stimulation intensity is adjusted dynamically, with a mandatory 2-minute rest every 10 minutes.
Treatment: Endovascular Venous BCI Type-A Sensor and BCI-Triggered Functional Electrical Stimulation
- Assistance Group (BCI Robotic Arm)Treatment being tested
Participants with ALS or severe paraplegia with no realistic prospect of recovering voluntary movement. After endovascular implantation of the venous BCI Type-A sensor, they complete decoder calibration during week 1, followed by daily 45-minute robotic arm training during weeks 2 to 4, in which decoded movement intention is used to control a bionic robotic arm for simulated daily tasks such as eating, grasping objects, and opening a door.
Treatment: Endovascular Venous BCI Type-A Sensor and BCI-Controlled Bionic Robotic Arm
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Venous Endovascular Brain-Computer Interface Type-A Sensor Combined With Functional Electrical Stimulation and Robotic Arm Assistance for Rehabilitation and Daily-Living Support in Patients With Movement Disorders
- Fit questions
- Built from NCT07934914, who can take part
- Record updated
- 13 November 2026